Harmony Biosciences: Q4 Earnings Insights - Harmony Biosciences (NASDAQ:HRMY)

Harmony Biosciences HRMY reported its Q4 earnings results on Monday, February 28, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Harmony Biosciences beat estimated earnings by 70.27%, reporting an EPS of $0.63 versus an estimate of $0.37.

Revenue was up $34.92 million from the same period last year.

Last quarter the company beat on EPS by $0.23 which was followed by a 1.02% increase in the share price the next day.

Here's a look at Harmony Biosciences's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	0.28	0.18	-0.03	0.09
EPS Actual	0.51	0.54	0.38	0.25
Revenue Estimate	79.85M	68.77M	57.07M	51.85M
Revenue Actual	80.73M	73.82M	59.67M	56.29M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.